Identifying Genes Uniquely Contributing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail
The Mark Foundation for Cancer Research announces a $1 million grant to The Jackson Laboratory (JAX) to study the harmful side effects that sometimes occur in cancer patients treated with immunotherapy. The research will involve mice engineered with humanized immune systems to find specific gene variants that could explain why so many patients - as many as 10 percent - develop Type 1 diabetes while undergoing immunotherapy to treat cancer. The grant will also study and determine how to predict which patients may experience myocarditis, a rare but potentially deadly inflammation of the heart that immunotherapy can also trigger.
This new grant project, Identifying Genes Uniquely Contributing to ICI-induced Immune Related Adverse Events, led by Professor Dave Serreze, Ph.D., and Scientific Director and Professor Nadia Rosenthal, Ph.D., F.Med.Sci., builds upon a $2.5 million grant the Mark Foundation awarded to JAX in 2019 aimed at determining how genetics influence i ....

United States , Michele Cleary , Ryan Schoenfeld , Nadia Rosenthal , Laura Reinholdt , Dave Serreze , Edisont Liu , Mark Foundation , Mark Foundation For Cancer Research , Jackson Laboratory , Cancer Research , Identifying Genes Uniquely Contributing , Immune Related Adverse Events , Professor Dave Serreze , Scientific Director , Professor Nadia Rosenthal , Associate Professor Laura Reinholdt , Accent Therapeutics , Verseau Therapeutics , ஒன்றுபட்டது மாநிலங்களில் , மைக்கேல் தெளிவானது , ரியான் ஸ்கோன்ஃபெல்ட் , நாடியா ரோசென்டல் , குறி அடித்தளம் , குறி அடித்தளம் க்கு புற்றுநோய் ஆராய்ச்சி , ஜாக்சன் ஆய்வகம் ,